HAEMATEMESIS Symptoms and Causes

We are sorry, but no medical information on this topic currently exists in our database. Our articles are updated often, please revisit soon.

Check out the latest treatments for HAEMATEMESIS

HAEMATEMESIS treatment research studies

Diclofenac clinical trials, surveys and public health registries

Find Drug Side Effect reports



Diclofenac Side Effects

Renal Failure Acute (154)
Abdominal Pain (139)
Diarrhoea (136)
Vomiting (128)
Dyspnoea (103)
Haemoglobin Decreased (103)
Gastrointestinal Haemorrhage (102)
Nausea (88)
Blood Creatinine Increased (88)
Anaemia (86)
Malaise (83)
Dehydration (82)
Pruritus (79)
Abdominal Pain Upper (77)
Blood Urea Increased (76)
Dizziness (72)
Gastric Ulcer (68)
Gastrointestinal Disorder (68)
Haematemesis (64)
Anaphylactic Reaction (62)
Pyrexia (61)
Erythema (60)
Fatigue (60)
Pain (60)
Hypotension (57)
Melaena (56)
Embolia Cutis Medicamentosa (54)
Chest Pain (54)
Arthralgia (53)
Rash (53)
Oedema Peripheral (51)
Asthenia (50)
Loss Of Consciousness (49)
Alanine Aminotransferase Increased (49)
Fall (48)
Headache (47)
Blood Alkaline Phosphatase Increased (47)
Metabolic Acidosis (46)
Gastritis (46)
Renal Failure (45)
Cardiac Arrest (44)
Confusional State (43)
Back Pain (43)
C-reactive Protein Increased (43)
Convulsion (43)
Urticaria (43)
Blood Pressure Decreased (41)
Weight Decreased (41)
Peritonitis (41)
Aspartate Aminotransferase Increased (40)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

HAEMATEMESIS Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
RankStatusStudy
1 Unknown Comparing Two Methods to Stop Vomiting of Blood Using the Endoscope
Conditions: Hematemesis;   Portal Hypertension
Intervention: Procedure: Endoscopic control of hematemesis
Outcome Measures: control of hematemesis;   occurence of complications from the intervention
2 Not yet recruiting Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy
Conditions: Dyspepsia;   Hematemesis;   Abdominal Pain;   Heartburn
Interventions: Drug: Anesthetics, Local;   Drug: Sodium Chloride 0.9%
Outcome Measures: Percentage of participants with 15% change in tolerability points according to Visual Analogue Scale (compared to baseline Visual Analogue Scale).;   Endoscopists´ procedural satisfaction points after the procedure assessed by using Visual Analogue Scale (VAS);   Cumulative consumption of alfentanil during the procedure (mg)
3 Recruiting Erythromycin Versus Gastric Lavage to Improve Quality of Endoscopy in Patients With Upper Gastrointestinal Bleeding
Conditions: Gastrointestinal Hemorrhage;   Hematemesis
Interventions: Drug: Erythromycin;   Procedure: gastric lavage
Outcome Measures: Visual quality of endoscopy;   need for a second-look endoscopy;   need of blood transfusion;   number of adverse events as a measure of safety and tolerability;   length of hospitalisation;   length of endoscopic procedure;   need for arteriography or surgery
4 Recruiting Tranexamic Acid for Upper Gastrointestinal Bleeding
Condition: Acute Upper Gastrointestinal Hemorrhage
Interventions: Drug: Early intravenous tranexamic acid administration;   Drug: placebo
Outcome Measures: Proportion of patients requiring early endoscopic treatment;   Endoscopic signs of bleeding;   Length of stay;   Need for urgent endoscopy;   Endoscopic procedure time/difficulty;   Need for transfusion;   Need for surgery/angiographic intervention;   rate of recurrent bleeding;   death of any cause;   thromboembolic complications
5 Recruiting Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.
Condition: Upper Gastrointestinal Bleeding
Interventions: Drug: Erythromycin;   Drug: Metoclopromide
Outcome Measures: 1. Wither erythromycin, metoclopromide vs control can enable visualization of the entire gastric mucosa .;   2. Wither erythromycin, metoclopromide vs control can improve the quality of stomach and duodenum visualization: using the scoring system by Fossard et al;   Ability to identify the source of bleeding;   Need for second-look endoscopy;   Mean number of blood units transfused;   All cause mortality
6 Not yet recruiting The Use of Hexacapron in Upper Gastrointestinal Bleeding
Conditions: Upper Gastrointestinal Bleeding;   Hexacapron;   Hemostasis;   Rebleeding;   Mortality
Interventions: Drug: Hexacapron( Tranexamic acid);   Drug: esomeprazole
Outcome Measures: Prevention of rebleeding manifested as hematemesis, melena and drop in hemoglobin level by 2g% within 24 hours after therapeutic endoscopy;   Rebleeding, need for surgery , 30 day mortality
7 Unknown Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal Bleeding
Condition: Nonvariceal Upper Gastrointestinal Bleeding
Interventions: Drug: Intravenous Omeprazole;   Drug: Oral Rabeprazole
Outcome Measure: This study aims to compare the effect of three-day oral rabeprazole and iv omeprazole on bleeding control in patients with mild to moderate non-variceal UGIB.
8 Unknown Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor
Conditions: Peptic Ulcer;   Ulcer Complications
Interventions: Drug: lansoprazole;   Drug: aluminum hydroxide 334 mg and Mg hydroxide 166 mg
Outcome Measures: The primary end point is the occurrence of clinical upper GI events (symptomatic ulcer and ulcer complications-bleeding, perforation, or obstruction);   The secondary end point is occurrence of dyspepsia, asymptomatic gastroduodenal ulcers
9 Unknown Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal Bleeding
Conditions: Esophageal and Gastric Varices;   Gastrointestinal Hemorrhage
Intervention: Drug: ceftrioxone
Outcome Measures: rebleeding rate within 14 days;   motarlity rate within 28 days

privacy policy